Investor Update: Cello Health puts in strong first half performance

Top stories from the Proactive Investors UK newsroom.

Healthcare marketing group Cello Health (LON:CLL) has reported a strong first six months of the year, with good like-for-like growth in overall net revenues and headline profit before tax. Margins have also improved and this year’s results will at least be in line with current market expectations.

Minds + Machines (LON:MMX) has also seen healthy revenue growth with domain name registrations up 19% to 1.82mln. Sales of the group’s original 28 domains rose by 30%.

OptiBiotix (LON:OPTI) has signed a distribution agreement with BioEnergiser that will see its SlimBiome Medical weight loss supplements sold online in the UK. Today’s deal gives BioEnergiser the right to distribute the supplements online within the UK, whilst still allowing Opti to continue to sell its product on its own online store.

Online fashion retailer ASOS has warned sales growth is being held back by  problems in the US with its new warehouse. Sales in the four months rose by 12% but ASOS says the US problem will continue for the rest of the year and is scaling back expectations accordingly. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Immotion plans fundraising following deal with Las Vegas resort

Immotion Group (LON:IMMO) has raised gross proceeds of £2.85mln from an 'oversubscribed' fundraising to accelerate its growth plans, and revealed it has inked a revenue-sharing deal with the MGM Mandalay Bay resort and casino in Las Vegas. CEO Martin Higginson tells Proactive London what the...

1 day, 3 hours ago

2 min read